Mike Fox brings over 30 years of commercial experience in the pharmaceutical industry to Achelios. He has broad experience in sales, marketing and business development in both domestic and international markets. He was the Director of Marketing at two Ophthalmic Pharmaceutical companies and responsible for the launch of Pharmacia’s flagship brand Xalatan. Most recently he was the Global New Business Development leader for Janssen Pharmaceutical’s Cardiovascular and Metabolic Franchise which recently launched Invokana, a novel product for the treatment of type 2 diabetes. Mike has a M.Ed. from the University of Delaware and a B.S. in Marine Science from Stockton University.